Charts Frazier Lifesciences Acquisition Corporation
Stocks
NAMS
NL00150012L7
Biotechnology & Medical Research
|
Real-time Estimate
Tradegate
13:14:44 2026-09-02 EDT
|
5-day change | 1st Jan Change | ||
| 22.06 EUR | -11.50% |
|
-8.85% | -28.96% |
| 08-26 | NewAmsterdam Pharma Presents Data From Obicetrapib Development Program At European Society Of Cardiology Congress 2026 | CI |
| 08-14 | Newamsterdam Pharma Company N.V. Announces Executive Changes | CI |
Chart: Technical Analysis
Stock exchange
Nasdaq
NAMS 24.92 €
-1.66%
17.8M
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| NAMS | 24.92EUR | -1.66% | 17.8M € | |
Nasdaq
| NAMS | 25.62USD | +2.81% | 8.56M $ | |
|
CBOE
| NAMS | 25.55USD | +2.65% | 498K $ | |
|
Tradegate
| KH6 | 21.99EUR | +2.28% | 2.55K € | |
|
Deutsche Boerse AG
| KH6 | 21.02EUR | 0.00% | 0 € | |
|
Börse Stuttgart
| KH6 | 21.98EUR | +2.66% | 0 € | |
|
Boerse Muenchen
| KH6 | 21.98EUR | +1.85% | 0 € |
- Stock Market
- Stocks
- NAMS Stock
- Charts Frazier Lifesciences Acquisition Corporation
Select your edition
All financial news and data tailored to specific country editions
